Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation by Valtola, Kati, Hedman, Marja, Kantola, Ilkka, Walls, Susanne, Helisalmi, Seppo, Maria, Maleeha, Raivo, Joose, Auray-Blais, Christiane, Kuusisto, Johanna

Get full text

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery by Halvorsen, Sigrun, Mehilli, Julinda, Cassese, Salvatore, Hall, Trygve S, Abdelhamid, Magdy, Barbato, Emanuele, De Hert, Stefan, de Laval, Ingrid, Geisler, Tobias, Hinterbuchner, Lynne, Ibanez, Borja, Lenarczyk, Radosław, Mansmann, Ulrich R, McGreavy, Paul, Mueller, Christian, Muneretto, Claudio, Niessner, Alexander, Potpara, Tatjana S, Ristić, Arsen, Sade, L Elif, Schirmer, Henrik, Schüpke, Stefanie, Sillesen, Henrik, Skulstad, Helge, Torracca, Lucia, Tutarel, Oktay, Van Der Meer, Peter, Wojakowski, Wojtek, Zacharowski, Kai

Get full text

Aging Fabry disease patients by Kantola, Ilkka, Hietaharju, Aki, Kuusisto, Johanna, Kylmälä, Minna M., Effati, Paivi Pietila, Taurio, Jyrki, Valtola, Kati, Yliaska, Iina, Saarinen, Jukka

Get full text

Fabry cardiomyopathy in Finland: A Fabry registry study by Effati, Paivi Pietila, Valtola, Kati, Walls, Susanne, Kantola, Ilkka, Kuusisto, Johanna

Get full text

Start age of enzyme replacement therapy (ERT) did not effect ECG parameters in Fabry disease patients (FD) treated by ERT for 5 years by Kantola, Ilkka, Annala, Antti-Pekka, Hietaharju, Aki, Helioe, Tiina M., Kantola, Taru-Tuuli, Kuusisto, Johanna, Effati, Paivi Pietila, Saarinen, Jukka, Taurio, Jyrki, Walls, Susanne, Valtola, Kati, Yliaska, Iina

Get full text

Family with the rare GLA-Thr410Ala mutation by Valtola, Kati, Kantola, Ilkka, Hedman, Marja, Maria, Maleeha, Laakso, Markku, Kuusisto, Johanna

Get full text

PQ interval, QRS duration and QTc interval increased in Fabry disease patients treated by enzyme replacement therapy both for 10 and 15 years by Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka, Sandini, Lorenzo, Taurio, Jyrki, Walls, Susanne, Valtola, Kati, Yliaska, Iina

Get full text

Deterioration in ECG parameters in Fabry females and males treated by enzyme replacement therapy either for 5 or 10 years by Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Ukkola, Olavi, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text

Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 yea... by Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Heliö, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Päivi, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Ukkola, Olavi, Valtola, Kati, Walls, Susanne, Yliaska, Iina

Get full text

PQ-interval and QRS duration increased in Fabry patients treated by enzyme replacement therapy for 12 years by Kantola, Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka, Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text

Enzyme replacement therapy carries for 4-7years in Fabry disease thereafter quality of life decreases by Kantola, I. Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kuusisto, Johanna, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text

Enzyme replacement therapy carries for 4-7 years in Fabry disease thereafter quality of life decreases by Kantola, I. Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kuusisto, Johanna, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text